273 related articles for article (PubMed ID: 27842517)
1. Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies.
Nobrega FL; Ferreira D; Martins IM; Suarez-Diez M; Azeredo J; Kluskens LD; Rodrigues LR
BMC Cancer; 2016 Nov; 16(1):881. PubMed ID: 27842517
[TBL] [Abstract][Full Text] [Related]
2. Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.
Silva VL; Ferreira D; Nobrega FL; Martins IM; Kluskens LD; Rodrigues LR
PLoS One; 2016; 11(8):e0161290. PubMed ID: 27548261
[TBL] [Abstract][Full Text] [Related]
3. Using phage as a platform to select cancer cell-targeting peptides.
Li X; Mao C
Methods Mol Biol; 2014; 1108():57-68. PubMed ID: 24243240
[TBL] [Abstract][Full Text] [Related]
4. High
Onaga C; Tamori S; Motomura H; Ozaki A; Matsuda C; Matsuoka I; Fujita T; Nozaki Y; Hara Y; Kawano Y; Harada Y; Sato T; Mano Y; Sato K; Akimoto K
Anticancer Res; 2021 Jan; 41(1):43-54. PubMed ID: 33419798
[TBL] [Abstract][Full Text] [Related]
5. "Blind" targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates.
Galbiati E; Gambini L; Civitarese V; Bellini M; Ambrosini D; Allevi R; Avvakumova S; Romeo S; Prosperi D
Pharmacol Res; 2016 Sep; 111():155-162. PubMed ID: 27293049
[TBL] [Abstract][Full Text] [Related]
6. BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters.
Madaras L; Balint N; Gyorffy B; Tokes AM; Barshack I; Yosepovich A; Friedman E; Paluch-Shimon S; Zippel D; Baghy K; Timar J; Kovalszky I; Kulka J; Szasz AM
Pathobiology; 2016; 83(1):1-12. PubMed ID: 26566278
[TBL] [Abstract][Full Text] [Related]
7. Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library.
Shukla GS; Krag DN
Oncol Rep; 2005 Apr; 13(4):757-64. PubMed ID: 15756454
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of a renal carcinoma specific peptide from a phage display peptide library.
Tu X; Zhuang J; Wang W; Zhao L; Zhao L; Zhao J; Deng C; Qiu S; Zhang Y
J Exp Clin Cancer Res; 2011 Nov; 30(1):105. PubMed ID: 22071019
[TBL] [Abstract][Full Text] [Related]
9. Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library.
Bakhshinejad B; Zade HM; Shekarabi HS; Neman S
Amino Acids; 2016 Dec; 48(12):2699-2716. PubMed ID: 27650972
[TBL] [Abstract][Full Text] [Related]
10. Selection of a new peptide homing SK-BR-3 breast cancer cells.
Pereira AC; Ferreira D; Santos-Pereira C; Vieira TF; Sousa SF; Sales G; Rodrigues LR
Chem Biol Drug Des; 2021 Apr; 97(4):893-903. PubMed ID: 33314617
[TBL] [Abstract][Full Text] [Related]
11. Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type.
Rust S; Guillard S; Sachsenmeier K; Hay C; Davidson M; Karlsson A; Karlsson R; Brand E; Lowne D; Elvin J; Flynn M; Kurosawa G; Hollingsworth R; Jermutus L; Minter R
Mol Cancer; 2013 Feb; 12():11. PubMed ID: 23406016
[TBL] [Abstract][Full Text] [Related]
12. Landscape phages and their fusion proteins targeted to breast cancer cells.
Fagbohun OA; Bedi D; Grabchenko NI; Deinnocentes PA; Bird RC; Petrenko VA
Protein Eng Des Sel; 2012 Jun; 25(6):271-83. PubMed ID: 22490956
[TBL] [Abstract][Full Text] [Related]
13. Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models.
Zhou C; Kang J; Wang X; Wei W; Jiang W
BMC Cancer; 2015 Nov; 15():889. PubMed ID: 26555399
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer.
Soudy R; Etayash H; Bahadorani K; Lavasanifar A; Kaur K
Mol Pharm; 2017 Mar; 14(3):593-604. PubMed ID: 28157321
[TBL] [Abstract][Full Text] [Related]
15. [Claudins as prognostic factors of breast cancer].
Szász MA
Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
[TBL] [Abstract][Full Text] [Related]
16. Cell surface profiling with peptide libraries yields ligand arrays that classify breast tumor subtypes.
Dane KY; Gottstein C; Daugherty PS
Mol Cancer Ther; 2009 May; 8(5):1312-8. PubMed ID: 19417151
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas.
Gerhard R; Ricardo S; Albergaria A; Gomes M; Silva AR; Logullo ÂF; Cameselle-Teijeiro JF; Paredes J; Schmitt F
Breast; 2012 Jun; 21(3):354-60. PubMed ID: 22464177
[TBL] [Abstract][Full Text] [Related]
18. Novel beta-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy.
Shukla GS; Krag DN
J Drug Target; 2010 Feb; 18(2):115-24. PubMed ID: 19751096
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic and prognosis features of Claudin-low breast cancers].
Xu J; Lan KT; Su TH; Li ZF; Wan Y; Gu QQ; Zou PC; Zou X
Zhonghua Bing Li Xue Za Zhi; 2017 Sep; 46(9):634-639. PubMed ID: 28910875
[No Abstract] [Full Text] [Related]
20. Identification and characterization of a novel phage display-derived peptide with affinity for human brain metastatic breast cancer.
Fu B; Zhang Y; Long W; Zhang A; Zhang Y; An Y; Miao F; Nie F; Li M; He Y; Zhang J; Teng G
Biotechnol Lett; 2014 Nov; 36(11):2291-301. PubMed ID: 25048232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
